Literature DB >> 31705767

Comparison of corneal biomechanical properties following penetrating keratoplasty and deep anterior lamellar keratoplasty for keratoconus.

Mohammed Ziaei1, Hans R Vellara1, Akilesh Gokul1, Noor Q Ali1, Charles N J McGhee1, Dipika V Patel1.   

Abstract

IMPORTANCE: Keratoplasty is a surgical procedure to create a more regular optical surface following biomechanical weakening of the cornea in keratoconus. The ideal keratoplasty procedure should also restore corneal biomechanics to that of the healthy cornea.
BACKGROUND: This study aimed to evaluate and compare the biomechanical properties of corneas following penetrating keratoplasty (PKP) and predescematic deep anterior lamellar keratoplasty (DALK) to those of healthy eyes.
DESIGN: Prospective cross-sectional study. PARTICIPANTS: Two cohorts of post-keratoplasty eyes (42 eyes with PKP and 27 eyes with DALK) with each other, and with a cohort of 152 healthy eyes.
METHODS: All eyes were examined by slit-lamp biomicroscopy, tomography, anterior segment-OCT and non-contact tonometry CorVis ST (CST). MAIN OUTCOME MEASURES: CST biomechanical parameters, maximum corneal deformation (MCD) and corneal energy dissipation were compared between keratoplasty techniques, and with healthy eyes.
RESULTS: The mean age of participants with PKP and DALK were 35 ± 13.7 and 36.1 ± 12.6 years, respectively. None of the CST parameters were significantly different between PKP and DALK eyes. However, when compared to healthy corneas, numerous parameters were significantly different for both keratoplasty techniques. Of note, MCD was significantly higher in PKP compared to DALK and healthy corneas, after controlling for co-factors. CONCLUSIONS AND RELEVANCE: Neither type of keratoplasty technique utilized in keratoconus completely restored corneal biomechanical properties to that of healthy corneas. However, PKP resulted in a greater number of parameters significantly different to healthy corneas, compared to DALK.
© 2019 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  DALK; PKP; biomechanics; cornea; corvis; keratoconus; keratoplasty

Mesh:

Year:  2019        PMID: 31705767     DOI: 10.1111/ceo.13677

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  6 in total

1.  Comparison of deep anterior lamellar keratoplasty and corneal cross-linking in patients with advanced keratoconus.

Authors:  Jinsong Xue; Haiou Wang; Min Wang; Qingyan Zeng; Vishal Jhanji; Andy D Kim; Michael T M Wang; Yingnan Xu; Xiuming Jin; Wei Chen
Journal:  Jpn J Ophthalmol       Date:  2021-11-29       Impact factor: 2.447

2.  Relationship between Postoperative Intraocular Pressure and Refractive Outcomes in Patients after Deep Anterior Lamellar Keratoplasty.

Authors:  Dayna Yong Wei Wei; Liang Shen; Ray Manotosh; Anna Tan Wee Tien; Charmaine Chai Hui-Chen
Journal:  J Curr Ophthalmol       Date:  2022-04-16

3.  Peripheral Cornea Crosslinking Before Deep Anterior Lamellar Keratoplasty.

Authors:  Mohammed Ziaei; Akilesh Gokul; Hans Vellara; Dipika Patel; Charles Nj McGhee
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2020-03-27

Review 4.  Corneal Biomechanical Assessment with Ultra-High-Speed Scheimpflug Imaging During Non-Contact Tonometry: A Prospective Review.

Authors:  Pedro Manuel Baptista; Renato Ambrosio; Luis Oliveira; Pedro Meneres; Joao Melo Beirao
Journal:  Clin Ophthalmol       Date:  2021-04-06

Review 5.  Penetrating Keratoplasty versus Deep Anterior Lamellar Keratoplasty for Keratoconus: A Systematic Review and Meta-analysis.

Authors:  Majid Shams; Ali Sharifi; Zahra Akbari; Ali Maghsoudlou; Mohammad Reza Tajali
Journal:  J Ophthalmic Vis Res       Date:  2022-01-21

Review 6.  Diagnostic imaging versus surgical procedure: intra- and postoperative OCT evaluation of sutureless scleral-fixated intraocular lens implantation and possible related complications.

Authors:  Raffaele Nuzzi; Alessandro Rossi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-03-12       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.